Table 2 The survival time in each part and T stage
Overall Survival time (month) | Relapse-free Survival (month) | Progression-free Survival (month) | ||
|---|---|---|---|---|
Bladder | ||||
T1 and lower stage | 147.86 ± 15.63 (95%CI: 117.22–178.50) | 21.28 ± 9.35 (95%CI: 2.95–39.61) | 43.39 ± 13.67 (95%CI: 16.69–70.28) | |
Upper-Tract | ||||
T1 and lower stage | 145.92 ± 12.60 (95%CI: 121.22-170.62) | - | 90.40 ± 14.21 (95%CI: 62.55-118.25) | |
T2 and higher stage | 168.06 ± 15.30 (95%CI: 138.07-198.05) | - | 108.23 ± 20.63 (95%CI: 67.81-148.65) | |
Upper-Tract and Bladder | ||||
T1 and lower stage | 112.92 ± 27.92 (95%CI:58.21-167.64) | 26.86 ± 4.81 (95%CI:17.42–36.29) | 48.92 ± 8.88 (95%CI:31.52–66.32) | |
T2 and higher stage | 79.62 ± 22.00 (95%CI:36.51-122.73) | 49.07 ± 18.21 (95%CI:13.38–84.77) | 171.776 ± 19.12 (95%CI:134.29-209.23) | |